MetLife (NYSE:MET) Board Declares Stock Repurchase Program

MetLife (NYSE:MET) announced that its board has authorized a stock buyback program on Wednesday, August 5th, RTT News reports. The company plans to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

MetLife Price Performance

Shares of NYSE MET opened at $97.61 on Friday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average price is $90.10 and its two-hundred day moving average price is $80.82. MetLife has a twelve month low of $67.33 and a twelve month high of $100.93. The company has a market cap of $62.81 billion, a PE ratio of 18.70, a price-to-earnings-growth ratio of 0.76 and a beta of 0.78.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.30 by $0.13. The company had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The company’s revenue was up 10.5% on a year-over-year basis. During the same period in the prior year, the firm earned $2.02 earnings per share. On average, analysts predict that MetLife will post 9.89 EPS for the current year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be given a dividend of $0.5925 per share. The ex-dividend date is Tuesday, August 4th. This represents a $2.37 annualized dividend and a yield of 2.4%. MetLife’s dividend payout ratio (DPR) is 45.93%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on MET. TD Cowen boosted their target price on MetLife from $87.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. JPMorgan Chase & Co. raised their price objective on shares of MetLife from $96.00 to $106.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. Jefferies Financial Group boosted their price objective on shares of MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a research report on Friday, July 10th. Wells Fargo & Company increased their target price on MetLife from $95.00 to $101.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Finally, Mizuho boosted their price target on MetLife from $95.00 to $102.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, MetLife presently has an average rating of “Moderate Buy” and a consensus price target of $100.71.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: New $3 billion buyback: MetLife’s board authorized repurchases of up to 4.8% of outstanding shares through open-market purchases. The program signals management’s confidence in the company’s valuation and could support earnings per share over time. MetLife outlines new $3B buyback authorization
• Positive Sentiment: Second-quarter earnings beat estimates: MetLife reported adjusted EPS of $2.43 versus consensus of $2.30, helped by higher investment income, favorable underwriting, and business-volume growth. Earnings also improved from $2.02 a year earlier. MetLife Tops Q2 Earnings Estimates
• Positive Sentiment: Organic growth remains a key strength: Management highlighted underwriting performance and volume expansion, while maintaining its 2026 MetLife Investment Management outlook of $240 million to $280 million. Analysts described the results as supportive of the long-term buy case. MetLife Q2 Earnings Beat Reaffirms the Buy Case
• Neutral Sentiment: Analysts remain cautiously optimistic: MetLife has outperformed the broader market over the past year, but valuation and the stock’s recent strength may leave less room for additional near-term gains. MetLife Stock Analyst Estimates and Ratings
• Negative Sentiment: Spread headwinds and higher expenses remain risks: Management’s upbeat earnings commentary was tempered by pressure from investment spreads and elevated expenses, which could weigh on future profit growth despite favorable underwriting and investment income. MetLife Delivers Strong Earnings Amid Spread Headwinds

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.